Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Cosmo Pharmaceuticals N.V.
  6. News
  7. Summary
    COPN   NL0011832936

COSMO PHARMACEUTICALS N.V.

(COPN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Cosmo Pharmaceuticals N : Logs Widened H1 Loss On Higher Expenses

07/30/2021 | 01:32am EDT


© MT Newswires 2021
All news about COSMO PHARMACEUTICALS N.V.
07/30COSMO PHARMACEUTICALS N : Logs Widened H1 Loss On Higher Expenses
MT
07/30EQS-ADHOC : Cosmo Half-Year Report 2021
DJ
07/30Cosmo Pharmaceuticals N.V. Reports Earnings Results for the Half Year Ended J..
CI
07/29EQS-ADHOC : Cassiopea Announces Results for First Half of 2021
DJ
07/26CASSIOPEA S P A : Enters License, Supply Deals for Acne Treatment in North Ameri..
MT
07/26EQS-ADHOC : Cosmo Pharmaceuticals Announces Cassiopea SpA's Signing of License a..
DJ
05/28EQS-ADHOC : Cosmo Pharmaceuticals' Shareholders approve all Agenda Items at Annu..
DJ
05/28COSMO PHARMACEUTICALS N : ' Shareholders approve all Agenda Items at Annual Gene..
EQ
05/10COSMO PHARMACEUTICALS N : announces a change in its board of directors
EQ
05/10Cosmo Pharmaceuticals N.V. Announces Resignation of Hans Christoph Tanner as ..
CI
More news
Analyst Recommendations on COSMO PHARMACEUTICALS N.V.
More recommendations
Financials
Sales 2021 60,8 M 71,2 M 71,2 M
Net income 2021 5,22 M 6,12 M 6,12 M
Net cash 2021 42,1 M 49,4 M 49,4 M
P/E ratio 2021 214x
Yield 2021 -
Capitalization 1 081 M 1 270 M 1 268 M
EV / Sales 2021 17,1x
EV / Sales 2022 13,4x
Nbr of Employees 276
Free-Float 45,1%
Chart COSMO PHARMACEUTICALS N.V.
Duration : Period :
Cosmo Pharmaceuticals N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends COSMO PHARMACEUTICALS N.V.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 75,43 €
Average target price 97,09 €
Spread / Average Target 28,7%
EPS Revisions
Managers and Directors
Niall Donnelly Chief Financial Officer & Head-Investor Relations
Mauro Severino Ajani Executive Chairman
Davide Malavasi Director-Qualified Person & Technical
Stefano Selva Chief Scientific Officer
H. Jurgen Lenz Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
COSMO PHARMACEUTICALS N.V.-2.94%1 270
JOHNSON & JOHNSON4.68%433 701
ROCHE HOLDING AG10.97%321 442
PFIZER, INC.20.81%246 078
NOVO NORDISK A/S50.80%232 556
ELI LILLY AND COMPANY36.28%208 604